What is All-Plastics?
All-Plastics distinguishes itself as a leading scientific injection plastic molding company, dedicated to producing high-precision components through advanced scientific molding techniques. The company's operational scope spans critical markets including pharmaceuticals, medical devices, industrial applications, packaging solutions, and consumer goods. By prioritizing the reduction of manufacturing costs alongside enhancements in product quality, All-Plastics leverages its commitment to continuous improvement and client-centric service. Its ISO 13485 certification serves as a testament to its rigorous adherence to superior quality and operational efficiency standards, ensuring both on-time delivery and comprehensive traceability for its clientele.
How much funding has All-Plastics raised?
All-Plastics has raised a total of $1.3M across 2 funding rounds:
Debt
$350K
Debt
$975K
Debt (2020): $350K with participation from PPP
Debt (2021): $975K led by PPP
What's next for All-Plastics?
The substantial enterprise-level funding and recent strategic investment indicate All-Plastics is poised for significant expansion and technological advancement. This capital infusion is likely to fuel further innovation in its scientific molding processes, potentially enabling the company to penetrate new markets or deepen its existing service offerings within the pharmaceutical and medical sectors. Strategic utilization of this financing could also involve scaling production capabilities, enhancing research and development for next-generation components, and fortifying its supply chain. The company's trajectory suggests a focus on solidifying its market leadership through continued investment in quality, efficiency, and advanced manufacturing technologies.
See full All-Plastics company page
